This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Centre National De La Recherche Scientifique. Active years: 2013-2021.
Company Filing History:
Years Active: 2013-2021
Title: The Innovative Contributions of Domenico Maiorano
Introduction
Domenico Maiorano is a notable inventor based in Saint Martin de Londres, France. He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 3 patents, his work focuses on advancing treatment options for tumors.
Latest Patents
One of Maiorano's latest patents is centered on the "Use of Rad18 inhibitors in the treatment of tumors." This invention relates to utilizing an inhibitor of Rad18 expression or activity to treat tumors or to sensitize patients affected by tumors to antineoplastic agents that are DNA damaging chemotherapeutic agents. This approach aims to reduce the self-renewal of cancer stem cells while enhancing the DNA damage response, ultimately boosting apoptotic cell death.
Another significant patent is the "Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions." This patent describes an isolated antibody that specifically binds to the C-terminus part of the MCM9 protein. The sequences involved are critical for the development of targeted therapies in cancer treatment.
Career Highlights
Domenico Maiorano is affiliated with the Centre National de La Recherche Scientifique, where he conducts his research and develops his innovative ideas. His work has been instrumental in pushing the boundaries of cancer treatment and understanding.
Collaborations
Maiorano has collaborated with esteemed colleagues such as Marcel Mechali and Malik Lutzmann. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.
Conclusion
Domenico Maiorano's contributions to cancer research through his patents demonstrate his commitment to improving treatment options for patients. His innovative work continues to inspire advancements in the medical field.